首页> 外国专利> USE OF BIS-SPECIFIC ANTIBODIES AGAINST AN ACTIVATING RECEPTOR FCEPSILONRI AND AN INHIBITIONAL RECEPTOR OX2RA (CD200RA) FOR REGULATING THE IMMUNE RESPONSES

USE OF BIS-SPECIFIC ANTIBODIES AGAINST AN ACTIVATING RECEPTOR FCEPSILONRI AND AN INHIBITIONAL RECEPTOR OX2RA (CD200RA) FOR REGULATING THE IMMUNE RESPONSES

机译:使用BIS特异性抗体对抗活化受体FCepsilonri和抑制性受体OX2RA(CD200RA)来调节免疫反应

摘要

The invention relates generally to the field of immunology, in particular, to bispecific antibodies. Methods for designing a bispecific antibody for use in treating diseases relating to the immune system are disclosed. Specific examples relate to bispecific antibodies which recognize an activating receptor and an inhibiting receptor.
机译:本发明总体上涉及免疫学领域,尤其涉及双特异性抗体。公开了设计用于治疗与免疫系统有关的疾病的双特异性抗体的方法。具体实例涉及识别激活受体和抑制受体的双特异性抗体。

著录项

  • 公开/公告号AT423571T

    专利类型

  • 公开/公告日2009-03-15

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号AT20020801055T

  • 申请日2002-10-11

  • 分类号A61K39/395;A61K47/48;C07K16/28;C07K16/46;

  • 国家 AT

  • 入库时间 2022-08-21 19:24:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号